维普中文期刊产品整合服务
152篇 您的检索式:作者名="Toren"
    题名 作者 年代 出处 被引量
1Evolving landscape and novel treatments in, metastatic castrate-resistant prostate cancer显示文摘为阉割抵抗的前列腺癌症(CRPC ) 的治疗选择在最近的年里进展了并且显著地与这好攻击、致命的疾病为病人改进了眼界。CRPC 的生物学的进一步的理解导致了几新指向的治疗并且继续强调雄激素受体(AR ) 的重要性指导了治疗。治疗风景很快生物学上正在改变并且推进基本原理,基于 biomarker 的进行中的临床的试用被需要。我们在 CRPC 考察主要临床的试用的最近的结果。新并且 investigational 代理人现在包括 angiogenesis,微导管,女伴, AR 和细胞内部的 kinases 的禁止者在临床的评估被考察,以及免疫疗法, radiopharmaceuticals 和指向骨头的代理人。在为 CRPC 的预后的最近的改进为进一步的改进带继续的乐观主义。对治疗的临床的考验和抵抗的机制的进一步的理解的有头脑的计划将允许在耐心的照顾的继续的进步。Paul J Toren Martin E Gleave 2013Asian Journal of Andrology2013,15,3:5
2Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias:May-Hegglin anomaly and Fechtner,Sebastian,Epstein,and Alport-like syndromes显示文摘Heath KE Campos-Barros A Toren A 2001Am J Hum Genet2001,69,:1
3Fish intake of Swedish male adolescents is a predictor of cognitive performance 显示文摘Aberg MA Aberg N Brisman J Sundberg R Winkvist A Toren K 2009Acta Paediatr2009,98,3:1
4Nature of the Electon Interactions in Aryl-substituted polysilanes显示文摘Pitt C G Carey R N Toren E C Jr 1972J Am Chem Soc1972,94,11:1
5Tractor-driving hours and their relation to self-reported low-back and hip symptoms显示文摘Toren 2002Applied Ergonomics2002,33,2:1
6Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal domi- nant macrothrombocytopenias : May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes 显示文摘Heath KE Campos-Barros A Toren A 2001Am J Hum Genet2001,1169,5:1
7Nature of the Electon Interactions in Aryl-substituted polysilanes显示文摘Pitt C G Carey R N Toren E C Jr 1972J Am Chem Soc1972,94,11:1
8Myofibroblasts in palatal wound healing:prospects for the reduetion of wound eontrae- tion after deft palate repair 显示文摘Van BeurdeB H E Von Den Hoff JW Toren SMA R 2005J Dent Res2005,84,10:1
9Muscle activity and range of motion during active trunk rota- tion in a sitting posture 显示文摘Toren A 2001Appl Ergon2001,32,6:1
10Signal transduction by reactive oxygen species 显示文摘Toren Finke 2011J Cell Bid2011,194,1:1
11The academic 'hurdle race': a case study显示文摘NINA TOREN DAHLIA MOORE 1998Higher Education1998,35,:1
12Evolving landscape and novel treatments in metastatic castrate -resistant prostate cancer显示文摘Toren PJ G|eave ME 2013Asian J Androl2013,15,3:1
13An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia 显示文摘Turetz M Mozes T Toren P 1997Br J Psychiatry1997,170,:1
14The determinants of the potential ef fectivenes: of government-supported industrial research in stitutes显示文摘TOREN N GALNI D 1978Research Policy1978,7,4:1
15Tractor-driving Hours and Their Relation to Self-reported Lowback and Hip Symptoms显示文摘Toren A Oberg K Lembke B 2002Applied Ergonomics2002,33,:1
16Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers显示文摘OLIN A C BAKE B TOReN K 2007Chest2007,131,6:1
17Nonmuscle myosin heavy chain ⅡA mutations define a spectrum of autosomal dominant macrothrombocytopenias:May-Hegglin anomaly and Fechtner,Sebastian,Epstein,and Alport-Like syndromes显示文摘Heath KE Campos-Barros A Toren A 2001Am J Hum Genet2001,69,:1
18Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery显示文摘RAMOT Y MEIRON M TOREN A 2009Toxicol Pathol2009,37,5:1
19Toward an integration of creative and critical thinking显示文摘Toren K 0,,01:1
20MYH9 spectrum of autosomal-dominant giant platelet syndromes:unexpected association with fibulin-1 variant-D inactivation显示文摘Toren A Rozenfeld-Granot G Heath KE 2003Am J Hematol2003,74,:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费